CellRapeutics™ Leukopak from Hepatitis B Donor (XS-0426-XU242)

Name: CellRapeutics™ Leukopak from Hepatitis B Donor
SKU: XS-0426-XU242
Rating: 5 (1 reviews)

Online Inquiry Datasheet

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Sourced from donors with laboratory-confirmed Hepatitis B Virus infection, this Leukopak offers a vital source of cells for studying chronic viral persistence versus clearance. The matrix contains HBV-specific T cells and B cells with varying degrees of "exhausted" phenotypes. It is specifically designed for the development of curative immunotherapies and the investigation of the intrahepatic-systemic immune axis in chronic hepatitis.

Specific Inquiry

Add to Cart

Donor Information

Product Name
CellRapeutics™ Leukopak from Hepatitis B Donor

Cat. No.
XS-0426-XU242

Donor Age
Middle-Aged

Donor Health
Confirmed HBV infection. The leukocyte profile reflects long-term viral exposure, showing specific anti-viral memory populations and signatures of chronic hepatic immune surveillance.

Ethnicity
Diverse backgrounds available.

Anticoagulant
Acid Citrate Dextrose or Heparin, specifically formulated to preserve the exhausted T-cell phenotype for downstream revitalization research.

Additional Donor Information
Each lot features a Leukopak from donors with documented HBV infection. Profiles include HBsAg/HBeAg status and viral load data, supporting research into T-cell exhaustion and chronic viral persistence.

Clinical Profile
Infection status, viral load, and history of antiviral treatment.

Additional Information

Medication History
Available upon request. Records of antiviral therapy and documentation of HBsAg/HBeAg status and viral load.

Formulation
Cryopreserved or Fresh options available.

Cell Purity
>90%

Cell Viability
>90%

Mycoplasma Testing
Negative

Sterility Testing
Negative

Genetic Stability Testing
The donor cells maintain their native genetic profile, exhibiting no karyotypic abnormalities or chromosomal instabilities typically associated with prolonged ex vivo expansion.

Application
Drug Discovery, Immuno-oncology Research

Research Use Only
RUO

Quality Control
Each product batch is strictly validated for high cellular viability, specific immune cell counts, and pathogen-free safety, ensuring consistent clinical phenotypes and ethical compliance for advanced immunological research.

Storage
Store fresh Leukopaks at 2°C to 8°C for immediate use, cryopreserved samples must be kept in liquid nitrogen vapor phase below -150°C.

Shiping
Dry Ice

Handling Notes
Process fresh cells within 48 hours or perform rapid thawing of cryovials in a 37°C water bath followed by gradual dilution to maximize recovery.

Warnings
Treat as potentially biohazardous human-derived material and handle strictly under BSL-2 guidelines using appropriate personal protective equipment.

Size
Full Bag, Half Bag

Keywords
CellRapeutics™ Leukopak from Hepatitis B Donor, Leukopak, Hepatitis B

Case Studies

Customer Reviews and Q&As

There are currently no customer reviews or questions for CellRapeutics™ Leukopak from Hepatitis B Donor (XS-0426-XU242). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.